Delivery Order SPE2DB22D3501-SPE2DB25FVK90
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,172.71 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used to treat Helicobacter pylori infections. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This award is a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,731.83 delivery order to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, with an ultimate completion date of June 20, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.90 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used in bacterial infection treatment. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this firm fixed-price delivery order. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pylera Capsule UU 120S pharmaceutical product, valued at $2,173.23, with a firm fixed price structure and a completion date of September 11, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.05 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120S, a pharmaceutical product, with an ultimate completion date of August 14, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Pylera Capsule UU 120s, a combination antibiotic medication used to treat Helicobacter pylori infections. The contract is valued at $2,266.10 under a firm fixed-price arrangement, with an ultimate completion date of April 25, 2025. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of PYLERA CAPSULE UU 120S. The contract has a ceiling value of $1,373.51 and a completion date of October 8, 2024. The contract is a firm fixed price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to various government...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $117,683.14 firm fixed-price contract is for the supply of PYLERA CAPSULE UU 120S, with a completion date of September 21, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999, which Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of PYLERA CAPSULE UU 120S, a pharmaceutical product, with a ceiling value of $2,736.99 and a completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and the...
- This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FASP0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,054.42, is for the delivery of PYLERA CAPSULE UU 120S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVK90Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,627.13 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used in treating Helicobacter pylori infections. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's continued performance under this vehicle reflects its established capability to meet federal procurement requirements through competitive open bidding and its critical role in the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/24/25 |